Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel

RT Gandhi, R Bedimo, JF Hoy, RJ Landovitz, DM Smith… - Jama, 2023 - jamanetwork.com
Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new …

Integrated care models: HIV and substance use

K Hill, I Kuo, SV Shenoi, MS Desruisseaux… - Current HIV/AIDS …, 2023 - Springer
Abstract Purpose of Review Behaviors and practices associated with substance use
contribute to lack of HIV virologic suppression and onward transmission. In the USA, many …

HIV associated neurocognitive disorders

L Zhou, NK Saksena - Infectious disease reports, 2013 - pmc.ncbi.nlm.nih.gov
Human immunodeficiency virus type 1 is associated with the development of neurocognitive
disorders in many infected individuals, including a broad spectrum of motor impairments and …

The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study

S Colledge-Frisby, N Jones, S Larney… - Drug and Alcohol …, 2022 - Elsevier
Background Injecting-related bacterial and fungal infections cause substantial illness and
disability among people who use illicit drugs. Opioid agonist treatment (OAT) reduces …

[HTML][HTML] Systematic review and meta-analysis of the effect of nerve block under ultrasound in ilioinguinal/iliohypogastric in children

J Chen, D Song, G Zheng, Y Luo - Translational Pediatrics, 2022 - ncbi.nlm.nih.gov
Background Ilioinguinal/iliohypogastric nerve block (IINB) is a common operation in
pediatric surgery. Nerve block under contrast-enhanced ultrasound (CEUS) has the …

[HTML][HTML] Positive contact and empathy as predictors of primary care providers' willingness to prescribe medications for opioid use disorder

LY Dhanani, WC Miller, OT Hall, DL Brook, JE Simon… - SSM-Mental …, 2023 - Elsevier
Introduction Patients with opioid use disorder (OUD) have a heightened need for quality
health care, including access to evidence-based medications to reduce cravings and …

Medicaid managed care restrictions on medications for the treatment of opioid use disorder

MT Stewart, CM Andrews, SR Feltus… - Health services …, 2024 - Wiley Online Library
Abstract Objective To examine whether Medicaid managed care plan (MCP) utilization
management policies for buprenorphine–naloxone and injectable naltrexone are related to …

Engaging healthcare teams to increase access to medications for opioid use disorder

RS Oberman, AK Huynh, K Cummings… - Health Services …, 2024 - Wiley Online Library
Objective To assess the effectiveness of evidence‐based quality improvement (EBQI) as an
implementation strategy to expand the use of medications for opioid use disorder (MOUD) …

A history of childhood maltreatment has substance-and sex-specific effects on craving during treatment for substance use disorders

S Gerhardt, K Eidenmueller, S Hoffmann… - Frontiers in …, 2022 - frontiersin.org
Rationale Childhood maltreatment (CM) leads to detrimental mental health outcomes, such
as substance use disorders (SUD). This study examined prevalence and severity of all five …

The cost of opioid use disorder-related conditions in Medicare

TL Mark, WJ Parish, EM Weber, DG Steinberg… - Drug and alcohol …, 2023 - Elsevier
Background Medicare coverage excludes some levels of substance use disorder (SUD)
care, such as intensive outpatient and residential treatment. Expanding access to SUD …